Literature DB >> 18047393

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.

Maria G Roubelakis1, Kalliopi I Pappa, Vasiliki Bitsika, Dimitra Zagoura, Antonia Vlahou, Helen A Papadaki, Aristidis Antsaklis, Nicholas P Anagnou.   

Abstract

Human mesenchymal stem cells (hMSCs) constitute a population of multipotent adherent cells able to give rise to multiple mesenchymal lineages such as osteoblasts, adipocytes, or chondrocytes. So far, the most common source of MSCs has been the bone marrow (BM); however BM-MSC harvesting and processing exhibits major drawbacks and limitations. Thus, identification and characterization of alternative sources of MSCs are of great importance. In the present study, we isolated and expanded fetal MSCs from second-trimester amniotic fluid (AF). We documented that these cells are of embryonic origin, can differentiate under appropriate conditions into cell types derived from all three germ layers, and express the pluripotency marker Oct-4, the human Nanog protein, and the stage-specific embryonic antigen-4 (SSEA-4). Furthermore, we systematically tested the immunophenotype of cultured MSCs by flow cytometry analysis using a wide variety of markers. Direct comparison of this phenotype to the one derived from cultured BM-MSCs demonstrated that cultured MSCs from both sources exhibit similar expression patterns. Using the two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) approach, we have generated for the first time the protein map of cultured AF-MSCs by identifying 261 proteins, and we compared it directly to that of cultured BM-MSCs. The functional pattern of the identified proteins from both sources was similar. However, cultured AF-MSCs displayed a number of unique proteins related to proliferation and primitive phenotype, which may confer to the distinct features of the two types. Considering the easy access to this new cell source and the yield of expanded MSCs for stem cell research, AF may provide an excellent source of MSCs both for basic research and for potential therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18047393     DOI: 10.1089/scd.2007.0036

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  86 in total

Review 1.  Unravelling the pluripotency paradox in fetal and placental mesenchymal stem cells: Oct-4 expression and the case of The Emperor's New Clothes.

Authors:  Jennifer M Ryan; Allison R Pettit; Pascale V Guillot; Jerry K Y Chan; Nicholas M Fisk
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 2.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

3.  Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells.

Authors:  Paz L González; Catalina Carvajal; Jimena Cuenca; Francisca Alcayaga-Miranda; Fernando E Figueroa; Jorge Bartolucci; Lorena Salazar-Aravena; Maroun Khoury
Journal:  Stem Cells Transl Med       Date:  2015-08-13       Impact factor: 6.940

4.  SOX9 as a Predictor for Neurogenesis Potentiality of Amniotic Fluid Stem Cells.

Authors:  Pei-Cih Wei; Angel Chao; Hsiu-Huei Peng; An-Shine Chao; Yao-Lung Chang; Shuenn-Dyh Chang; Hsin-Shih Wang; Yu-Jen Chang; Ming-Song Tsai; Martin Sieber; Hua-Chien Chen; Shu-Jen Chen; Yun-Shien Lee; Shiaw-Min Hwang; Tzu-Hao Wang
Journal:  Stem Cells Transl Med       Date:  2014-08-25       Impact factor: 6.940

Review 5.  [Stem cell therapy and tissue engineering in regenerative urology].

Authors:  M Vaegler; B Amend; W Aicher; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2013-12       Impact factor: 0.639

Review 6.  Advances in cell culture: anchorage dependence.

Authors:  Otto-Wilhelm Merten
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-02-05       Impact factor: 6.237

Review 7.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

Review 8.  Reviewing and updating the major molecular markers for stem cells.

Authors:  Raquel Calloni; Elvira Alicia Aparicio Cordero; João Antonio Pêgas Henriques; Diego Bonatto
Journal:  Stem Cells Dev       Date:  2013-01-22       Impact factor: 3.272

9.  The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells.

Authors:  Katharina Wolfrum; Ying Wang; Alessandro Prigione; Karl Sperling; Hans Lehrach; James Adjaye
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Transcriptional analysis of fracture healing and the induction of embryonic stem cell-related genes.

Authors:  Manish Bais; Jody McLean; Paola Sebastiani; Megan Young; Nathan Wigner; Temple Smith; Darrell N Kotton; Thomas A Einhorn; Louis C Gerstenfeld
Journal:  PLoS One       Date:  2009-05-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.